SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/B5BDC2DCF3FC68FD904C416840F222489C91DAA5EEC714ADED99A4B9F017F560965719DDE479B206DD9EEE6B4526B870>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/B5BDC2DCF3FC68FD904C416840F222489C91DAA5EEC714ADED99A4B9F017F560965719DDE479B206DD9EEE6B4526B870
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/B5BDC2DCF3FC68FD904C416840F222489C91DAA5EEC714ADED99A4B9F017F560965719DDE479B206DD9EEE6B4526B870
http://www.w3.org/2000/01/rdf-schema#comment
"The finding of recurrent activating JAK3 mutations in patients with T-PLL could enable the use of JAK3 inhibitors to treat patients with this unfavorable malignancy who otherwise have a very poor prognosis."
xsd:string
http://purl.uniprot.org/uniprot/#_3E13EAC09EF0A66D934406AFE19FF0E7115CAD9347AF31D96D5FAAF0FDECDDC5415FF48DF0D1D5F7A79265CE3AC36239
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/B5BDC2DCF3FC68FD904C416840F222489C91DAA5EEC714ADED99A4B9F017F560965719DDE479B206DD9EEE6B4526B870
http://purl.uniprot.org/uniprot/Q9UMU1
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/B5BDC2DCF3FC68FD904C416840F222489C91DAA5EEC714ADED99A4B9F017F560965719DDE479B206DD9EEE6B4526B870
http://purl.uniprot.org/uniprot/#_Q9UMU1-mappedCitation-24446122
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/B5BDC2DCF3FC68FD904C416840F222489C91DAA5EEC714ADED99A4B9F017F560965719DDE479B206DD9EEE6B4526B870